 |
PDBsum entry 2fbx
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class 1:
|
 |
E.C.3.1.-.-
|
|
 |
 |
 |
 |
 |
Enzyme class 2:
|
 |
E.C.3.6.4.12
- Dna helicase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
ATP + H2O = ADP + phosphate + H+
|
 |
 |
 |
 |
 |
ATP
|
+
|
H2O
|
=
|
ADP
|
+
|
phosphate
|
+
|
H(+)
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Note, where more than one E.C. class is given (as above), each may
correspond to a different protein domain or, in the case of polyprotein
precursors, to a different mature protein.
|
|
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
Nat Struct Mol Biol
13:414-422
(2006)
|
|
PubMed id:
|
|
|
|
|
| |
|
WRN exonuclease structure and molecular mechanism imply an editing role in DNA end processing.
|
|
J.J.Perry,
S.M.Yannone,
L.G.Holden,
C.Hitomi,
A.Asaithamby,
S.Han,
P.K.Cooper,
D.J.Chen,
J.A.Tainer.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
WRN is unique among the five human RecQ DNA helicases in having a functional
exonuclease domain (WRN-exo) and being defective in the premature aging and
cancer-related disorder Werner syndrome. Here, we characterize WRN-exo crystal
structures, biochemical activity and participation in DNA end joining. Metal-ion
complex structures, active site mutations and activity assays reveal a nuclease
mechanism mediated by two metal ions. The DNA end-binding Ku70/80 complex
specifically stimulates WRN-exo activity, and structure-based mutational
inactivation of WRN-exo alters DNA end joining in human cells. We furthermore
establish structural and biochemical similarities of WRN-exo to DnaQ-family
replicative proofreading exonucleases, describing WRN-specific adaptations
consistent with double-stranded DNA specificity and functionally important
conformational changes. These results indicate WRN-exo is a human DnaQ family
member and support DnaQ-like proofreading activities stimulated by Ku70/80, with
implications for WRN functions in age-related pathologies and maintenance of
genomic integrity.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 2.
Figure 2. WRN-exo metal-ion dependence and structural analyses.
(a) Nuclease activity assays containing WRN-exo (50 pmol) and
radiolabeled DNA substrate were incubated for 30 min with either
no metal (control; lane 1) or the noted divalent cation(s).
WRN-exo 3' arrow
5' dsDNA nuclease activity is supported by Mg^2+ or Mn^2+ ions,
but not by Eu^2+ or in the absence of divalent cations. Addition
of Eu^2+ inhibits nuclease activity in the presence of equimolar
Mg^2+ or Mn^2+ ions. The DNA digestion pattern with equimolar
Mg^2+ and Mn^2+ is indistinguishable from that of Mn^2+ alone.
(b) Two Mn^2+ ions (purple) are chelated in the WRN active site
in the absence of DNA; dashed magenta lines denote metal-ion
bonds, with distances labeled. The inner metal ion, M[A], is
directly coordinated by Asp82, Glu84 and Asp216, and the outer
metal ion, M[B], directly ligates one side chain, Asp82, that
bridges the two metal ions. Asp143 has an indirect interaction
with the M[B] metal ion via two water molecules. (c) The WRN
active site also accommodates two of the larger lanthanide Eu^3+
ions (blue) in the absence of substrate. Dashed blue lines
denote metal-ion bonds. (d) Overlay of WRN Mn^2+ and Eu^3+
metal-ion complex structures, colored as in b and c.
Incorporation of Eu^3+ metal ions at sites M[A] and M[B] does
not cause appreciable changes in the WRN active site.
|
 |
Figure 6.
Figure 6. WRN-exo hexameric ring model and dGMP-binding site,
and altered processing by the W145A mutant. (a) The WRN ring
homology model, with differently colored WRN-exo subunits, was
built by structural superimposition with the A. thaliana homolog
(PDB entry 1VK0). The active site of the exonuclease (with gray
spheres denoting metal ions) faces the center of the ring. The
central cavity of the WRN ring is large enough (about 30 Å
in diameter by 35 Å deep) to accommodate dsDNA and is
similar to that observed in Ku70/80 (ref. 49). (b) DNA
processing is altered in a WRN-exo W145A mutant. Control
reactions with DNA alone or with 10 pmol of Ku70/80 are
indicated. WRN-exo and W145A reactions contained 20 fmol of
radiolabeled dsDNA substrate, approximately 200 pmol of each WRN
nuclease variant and increasing amounts of Ku70/80 (0.06, 0.6
and 6 pmol), denoted by triangles. (c) F[o] - F[c] electron
density map of WRN-exo dGMP soak (blue, 3 ;
red, 5 ).
dGMP stacks against Trp145, consistent with this region
interacting with DNA substrate at the center of the ring. (d)
Similar internal and external dimensions of the WRN-exo hexamer
model (right) and Ku70/80 bound to DNA (left) suggest a possible
interaction mode, which would place the protruding 2-
3
loop (left face) adjacent to the Ku dimer and/or allow Ku to
provide a suitable DNA orientation.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from Macmillan Publishers Ltd:
Nat Struct Mol Biol
(2006,
13,
414-422)
copyright 2006.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
M.Aggarwal,
J.A.Sommers,
R.H.Shoemaker,
and
R.M.Brosh
(2011).
Inhibition of helicase activity by a small molecule impairs Werner syndrome helicase (WRN) function in the cellular response to DNA damage or replication stress.
|
| |
Proc Natl Acad Sci U S A,
108,
1525-1530.
|
 |
|
|
|
|
 |
W.Yang
(2011).
Nucleases: diversity of structure, function and mechanism.
|
| |
Q Rev Biophys,
44,
1.
|
 |
|
|
|
|
 |
Y.Y.Hsiao,
C.C.Yang,
C.L.Lin,
J.L.Lin,
Y.Duh,
and
H.S.Yuan
(2011).
Structural basis for RNA trimming by RNase T in stable RNA 3'-end maturation.
|
| |
Nat Chem Biol,
7,
236-243.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
A.Smogorzewska,
R.Desetty,
T.T.Saito,
M.Schlabach,
F.P.Lach,
M.E.Sowa,
A.B.Clark,
T.A.Kunkel,
J.W.Harper,
M.P.Colaiácovo,
and
S.J.Elledge
(2010).
A genetic screen identifies FAN1, a Fanconi anemia-associated nuclease necessary for DNA interstrand crosslink repair.
|
| |
Mol Cell,
39,
36-47.
|
 |
|
|
|
|
 |
J.E.Deweese,
and
N.Osheroff
(2010).
The use of divalent metal ions by type II topoisomerases.
|
| |
Metallomics,
2,
450-459.
|
 |
|
|
|
|
 |
K.A.Hoadley,
and
J.L.Keck
(2010).
Werner helicase wings DNA binding.
|
| |
Structure,
18,
149-151.
|
 |
|
|
|
|
 |
K.K.Dhillon,
J.M.Sidorova,
T.M.Albertson,
J.B.Anderson,
W.C.Ladiges,
P.S.Rabinovitch,
B.D.Preston,
and
R.J.Monnat
(2010).
Divergent cellular phenotypes of human and mouse cells lacking the Werner syndrome RecQ helicase.
|
| |
DNA Repair (Amst),
9,
11-22.
|
 |
|
|
|
|
 |
A.Vindigni,
and
I.D.Hickson
(2009).
RecQ helicases: multiple structures for multiple functions?
|
| |
HFSP J,
3,
153-164.
|
 |
|
|
|
|
 |
I.Boubriak,
P.A.Mason,
D.J.Clancy,
J.Dockray,
R.D.Saunders,
and
L.S.Cox
(2009).
DmWRNexo is a 3'-5' exonuclease: phenotypic and biochemical characterization of mutants of the Drosophila orthologue of human WRN exonuclease.
|
| |
Biogerontology,
10,
267-277.
|
 |
|
|
|
|
 |
P.L.Opresko,
G.Sowd,
and
H.Wang
(2009).
The Werner syndrome helicase/exonuclease processes mobile D-loops through branch migration and degradation.
|
| |
PLoS ONE,
4,
e4825.
|
 |
|
|
|
|
 |
A.Sallmyr,
A.E.Tomkinson,
and
F.V.Rassool
(2008).
Up-regulation of WRN and DNA ligase IIIalpha in chronic myeloid leukemia: consequences for the repair of DNA double-strand breaks.
|
| |
Blood,
112,
1413-1423.
|
 |
|
|
|
|
 |
E.D.Garcin,
D.J.Hosfield,
S.A.Desai,
B.J.Haas,
M.Björas,
R.P.Cunningham,
and
J.A.Tainer
(2008).
DNA apurinic-apyrimidinic site binding and excision by endonuclease IV.
|
| |
Nat Struct Mol Biol,
15,
515-522.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
J.E.Deweese,
A.B.Burgin,
and
N.Osheroff
(2008).
Human topoisomerase IIalpha uses a two-metal-ion mechanism for DNA cleavage.
|
| |
Nucleic Acids Res,
36,
4883-4893.
|
 |
|
|
|
|
 |
R.D.Saunders,
I.Boubriak,
D.J.Clancy,
and
L.S.Cox
(2008).
Identification and characterization of a Drosophila ortholog of WRN exonuclease that is required to maintain genome integrity.
|
| |
Aging Cell,
7,
418-425.
|
 |
|
|
|
|
 |
R.Gupta,
and
R.M.Brosh
(2008).
Helicases as prospective targets for anti-cancer therapy.
|
| |
Anticancer Agents Med Chem,
8,
390-401.
|
 |
|
|
|
|
 |
R.Kusumoto,
L.Dawut,
C.Marchetti,
J.Wan Lee,
A.Vindigni,
D.Ramsden,
and
V.A.Bohr
(2008).
Werner protein cooperates with the XRCC4-DNA ligase IV complex in end-processing.
|
| |
Biochemistry,
47,
7548-7556.
|
 |
|
|
|
|
 |
Z.Bukowy,
J.A.Harrigan,
D.A.Ramsden,
B.Tudek,
V.A.Bohr,
and
T.Stevnsner
(2008).
WRN Exonuclease activity is blocked by specific oxidatively induced base lesions positioned in either DNA strand.
|
| |
Nucleic Acids Res,
36,
4975-4987.
|
 |
|
|
|
|
 |
C.D.Putnam,
M.Hammel,
G.L.Hura,
and
J.A.Tainer
(2007).
X-ray solution scattering (SAXS) combined with crystallography and computation: defining accurate macromolecular structures, conformations and assemblies in solution.
|
| |
Q Rev Biophys,
40,
191-285.
|
 |
|
|
|
|
 |
J.A.Harrigan,
J.Piotrowski,
L.Di Noto,
R.L.Levine,
and
V.A.Bohr
(2007).
Metal-catalyzed oxidation of the Werner syndrome protein causes loss of catalytic activities and impaired protein-protein interactions.
|
| |
J Biol Chem,
282,
36403-36411.
|
 |
|
|
|
|
 |
J.J.Perry,
L.Fan,
and
J.A.Tainer
(2007).
Developing master keys to brain pathology, cancer and aging from the structural biology of proteins controlling reactive oxygen species and DNA repair.
|
| |
Neuroscience,
145,
1280-1299.
|
 |
|
|
|
|
 |
K.Kitano,
N.Yoshihara,
and
T.Hakoshima
(2007).
Crystal structure of the HRDC domain of human Werner syndrome protein, WRN.
|
| |
J Biol Chem,
282,
2717-2728.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
L.S.Cox,
and
R.G.Faragher
(2007).
From old organisms to new molecules: integrative biology and therapeutic targets in accelerated human ageing.
|
| |
Cell Mol Life Sci,
64,
2620-2641.
|
 |
|
|
|
|
 |
U.de Silva,
S.Choudhury,
S.L.Bailey,
S.Harvey,
F.W.Perrino,
and
T.Hollis
(2007).
The crystal structure of TREX1 explains the 3' nucleotide specificity and reveals a polyproline II helix for protein partnering.
|
| |
J Biol Chem,
282,
10537-10543.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
L.Wu,
and
I.D.Hickson
(2006).
DNA helicases required for homologous recombination and repair of damaged replication forks.
|
| |
Annu Rev Genet,
40,
279-306.
|
 |
|
|
|
|
 |
M.P.Killoran,
and
J.L.Keck
(2006).
Sit down, relax and unwind: structural insights into RecQ helicase mechanisms.
|
| |
Nucleic Acids Res,
34,
4098-4105.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
');
}
}
 |